Stock screenerAll disclosures →
EDGAR →
KLRS
Conviction 4HealthcareScan · Mon, Aug 10, 2026KLRS$3.95-2.95%
ResistanceSupportVol 14Insider buy5
Vol MA14 93.37K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price3.95
Change-2.95%
Gap+0.25%
Rel volume0.07×
Avg volume665.81K
Avg $ vol2.87M
SMA 204.01
SMA 504.30
SMA 2006.52
Price vs 50-8.08%
Price vs 200-39.44%
MA stackbearish
50/200 cross—
Supertrenddown · 4.58
RSI (14)46
MACD hist0.06
MACD crossbull · 4d
Stoch %K / %D67 / 72
ADX (14)14
+DI / −DI26 / 21
RSI divergence—
MACD divergence—
ATR %+9.57%
ADR %11.04%
52w high10.98
52w low2.27
From 52w high-64.03%
Above 52w low+74.01%
New 52w highNo
SqueezeOff
Bollinger width40.16%
%B0.46
Donchian pos28.57%
Donchian high6.25
Donchian low3.03
AVWAP (52w high)5.87
vs AVWAP high-32.66%
AVWAP (52w low)5.66
vs AVWAP low-30.26%
OBV trendDown
Chaikin MF (20)-0.74
Today vs 20d0.07×
Avg vol (14d)93.37K
Avg vol (20d)665.81K
Avg $ vol (20d)2.87M
Market cap93.98M
RS 3m (vs SPY)-26.67%
RS 6m (vs SPY)-65.37%
RS line new highNo
Trend template1/8
Technical rank8.7
1 week-2.47%
1 month-11.04%
3 months-22.24%
6 months-52.64%
1 year+45.76%
YTD-52.41%
P/E-2.16
P/B1.37
P/S569.57
P/FCF-2.44
EPS-2.85
Div yield—
ROE-63.36%
ROA-39.56%
Debt/Eq—
Current12.19
EV/EBITDA-1.30
Gross margin—
Net margin—
Rev growth—
EPS growth37.20%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value59.55M
Revenue165K
Net income-10.86M
Gross profit—
Free cash flow-38.57M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out23.79M
Employees20
ListedWed, Mar 19, 2025
Free float3.17M
Float %17.0%
Short interest520.19K
Days to cover11.7d
Short volume19.8%
Squeeze score58 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank8.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.58
Support3.28
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KLRS
No recent disclosed trades by Congress in KLRS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KLRS · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
AKKARAJU SRINIVAS Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
Ferrara Napoleone Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
Hallal David Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
ADAMIS ANTHONY P Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
Jovan-Embiricos Morana Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
PATTERSON LEONE D Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
Dybbs Michael Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 9K | $0 | 2026-06-03 | 2026-06-04 |
AKKARAJU SRINIVAS Director · Common Stock · 2026-05-20 | Buy | 244.3K | $1.2M | 2026-05-20 | 2026-05-22 |
AKKARAJU SRINIVAS Director · Common Stock · 2026-05-20 | Acquire | 14.94K | $0 | 2026-05-20 | 2026-05-22 |
AKKARAJU SRINIVAS Director · Common Stock · 2026-05-20 | Acquire | 4.47K | $0 | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in KLRS · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.